Kala Pharmaceuticals Inc (KALA) Insider Trading
- $112,097,301.57
- $2,055,803.10
- June 24, 2025
- Mark T Iwicki
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 19, 2018 | Major Shareholder | 74,931 | $14.95 | Buy | $1,120,218.45 | |
| Jan. 12, 2018 | Major Shareholder | 240,484 | $13.28 | Buy | $3,193,627.52 | |
| Jan. 10, 2018 | Major Shareholder | 170,338 | $12.83 | Buy | $2,185,436.54 | |
| July 25, 2017 | Director | 533,333 | $15.00 | Buy | $7,999,995.00 | |
| July 25, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 | |
| July 25, 2017 | Insider | 319,333 | $15.00 | Buy | $4,789,995.00 | |
| July 20, 2017 | Major Shareholder | 215,000 | $15.00 | Buy | $3,225,000.00 |
Insiders are both buying and selling Kala Pharmaceuticals Inc stock.
The insider traders at Kala Pharmaceuticals Inc are: Mark T Iwicki, Orbimed Advisors Llc, Todd Bazemore, Mary Reumuth, Eric Trachtenberg, Darius Kharabi, Romulus K Brazzell, Ra Capital Management, L.P., Rajeev M Shah, Hongming Chen, Bros. Advisors Lp Baker, Ra Capital Healthcare Fund Lp, Associates L.L.C. Cdk, Howard B Rosen, Longitude Capital Partners Ii,, Mark T. Iwicki, and Gregory Grunberg
The most active insider trader at Kala Pharmaceuticals Inc is Mark T Iwicki with 10 trades.
Ra Capital Management, L.P. has sold the most Kala Pharmaceuticals Inc stock with a total value of $2,017,487.56.
Rajeev M Shah has bought the most Kala Pharmaceuticals Inc stock with a total value of $107,999,985.30.
The most recent insider trade for Kala Pharmaceuticals Inc was on June 24, 2025.
The single biggest insider buy for Kala Pharmaceuticals Inc was from Rajeev M Shah with a total value of $49,999,995.15 on March 13, 2020.
The single biggest insider sell for Kala Pharmaceuticals Inc was from Ra Capital Management, L.P. with a total value of $812,500.00 on May 23, 2022.